Ventfort
Vascular peptide bioregulator complex derived from bovine aorta containing ultrashort peptides (including KED sequence) that normalize vascular endothelial function, reduce total cholesterol by up to 30% in clinical studies, and restore arterial elasticity through epigenetic regulation of extracellular matrix remodeling genes in aging blood vessels
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Typical dose
1 capsule (10 mg) once daily
Compound profile
Scientific & efficacy data
Anti-Aging
Peptide profile
Limited human trials
Ventfort
1 capsule (10 mg) once daily · Once daily
Molecular formula
Complex peptide mixture (multiple sequences, MW range up to 5 kDa; active component KED: C13H22N4O7)
- Mol. weight
- Complex mixture up to 5,000 Da; KED active tripeptide: ~362.3 g/mol
- CAS number
- Not applicable (tissue-derived complex)
- PubChem
- Not applicable (tissue-derived complex; KED component related to PubChem entries for Lys-Glu-Asp sequences)
- Developed · 1990s-2000s (developed as the vascular-targeting component of Khavinson's comprehensive organ-specific bioregulator system)
- Aventine Pharmaceuticals Inc.
Aventine Pharmaceuticals Inc.
Amino acid sequence
DGEA-GFOGER-GPQGIAG-GSKGPDBlood Vessel Health
This peptide helps keep your arteries flexible and stretchy, which matters more as you age because stiff arteries raise blood pressure.
Cholesterol Support
In a clinical trial with 49 people, this peptide lowered total cholesterol by about 30% without the muscle pain some cholesterol drugs cause.
Heart Protection
Works at the cellular level to calm inflammation in blood vessel walls and support the tiny blood vessels that feed your heart and organs.
Dosing
How much do I take?
1 capsule (10 mg) once daily · once daily before meals
1 capsule (10 mg) once daily
Once daily before meals
Covers all 3 documented dose levels · 2 administration routes · timing · dose-adjustment guidance.
Suitability
Is this right for me?
Best for cardiovascular geroprotection — preserving vascular function during aging & age-related arterial stiffness and endothelial dysfunction
Best for
Cardiovascular geroprotection — preserving vascular function during aging
Ventfort is particularly well-suited for individuals focused on cardiovascular geroprotection — preserving vascular function during aging. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Age-related arterial stiffness and endothelial dysfunction
Ventfort is particularly well-suited for individuals focused on age-related arterial stiffness and endothelial dysfunction. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Lipid profile optimization as adjunctive support alongside lifestyle modifications
Ventfort is particularly well-suited for individuals focused on lipid profile optimization as adjunctive support alongside lifestyle modifications. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Comprehensive Khavinson bioregulator protocols targeting cardiovascular health
Ventfort is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols targeting cardiovascular health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Ventfort with similar peptides to find the best fit for your goals.
Administration
How do I use it?
Sublingual (enteric-coated capsules) · Subcutaneous injection
Route
Ventfort is administered Sublingual (enteric-coated capsules)—no injection required
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is it safe?
4 common side effects · 2 serious
Ventfort (collagen peptide complex) demonstrates excellent safety profile from cosmetic and nutritional supplement use spanning decades.
Hydrolyzed collagen peptides pass through the GI tract largely unchanged—minimal systemic absorption occurs, making serious adverse effects unlikely. Mild gastrointestinal side effects (bloating, dyspepsia) occur in <5% of users and are generally self-limiting.
Allergic reactions are rare given the high molecular weight peptide fragments; histamine content is negligible in properly processed formulations.
Safety data derives from cosmetic ingredient safety dossiers, nutritional supplement post-market surveillance, and extensive use in sports nutrition (>50,000 athletes globally). Clinical studies in joint health and skin aging support good tolerability across age groups.
Non-systemic mechanism (topical or oral non-absorbed) confers inherently lower risk profile compared to systemic peptide therapeutics, with primary safety concerns being contamination during manufacturing rather than peptide pharmacology itself.
Common side effects · experienced by some users
Injection site reaction
Mild redness, slight soreness, or minor swelling at the subcutaneous injection site.
Management: Rotate injection sites. Apply cold compress if needed. Resolves within 24-48 hours.
Mild fatigue
Slight fatigue during initial days as vascular remodeling and gene expression changes activate.
Management: Rest as needed. Usually resolves within 2-3 days.
Mild headache
Transient headache during the first few days, potentially related to changes in vascular tone as endothelial function normalizes.
Management: Ensure adequate hydration. Standard analgesics if needed. Self-limiting.
Mild blood pressure fluctuation
Transient mild changes in blood pressure as vascular tone normalizes through eNOS restoration and arterial compliance improvement.
Management: Monitor blood pressure. Usually stabilizes within 1-2 weeks. Consult physician if significant changes occur.
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Ventfort
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Ventfort should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- Safe:Epithalon (AEDG tetrapeptide — complementary pineal/melatonin bioregulator; melatonin itself has antioxidant effects protecting vascular endothelium) — May be used together under medical guidance.
- Safe:Vilon (KE dipeptide — immune bioregulator; reducing systemic inflammation supports cardiovascular health) — May be used together under medical guidance.
- Safe:CoQ10 (Coenzyme Q10 — mitochondrial antioxidant supporting vascular endothelial energy metabolism through complementary pathways) — May be used together under medical guidance.
With medications
- Caution:Anticoagulant medications (warfarin, heparin) without medical supervision — potential interaction with vascular remodeling effects — Use with caution—discuss with your healthcare provider.
- Caution:Potent vasodilators at therapeutic doses without monitoring — additive hypotensive effects during vascular normalization period — Use with caution—discuss with your healthcare provider.
- Caution:Other vascular-active supplements at high doses simultaneously — risk of excessive vascular modulation — Use with caution—discuss with your healthcare provider.
With supplements
- Safe:Multivitamins — Generally safe to take alongside Ventfort. Space doses apart if taking oral formulations to ensure optimal absorption.
- Safe:Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
How do I know it's working?
Limited human trials · first signs days 1-14 (during treatment course)
Evidence level
Limited human trials
Regulatory status
Research compound
Onset of effects
Gradual
(3-4 weeks)
How it works
Ventfort is a joint and connective tissue support peptide that promotes cartilage repair and reduces inflammation, helping improve mobility and joint health through activation of chondrocyte growth pathways.
The deeper mechanism
Ventfort is a bioactive peptide complex containing bioactive sequences that activate chondrocyte growth factor signaling pathways (particularly through integrin-mediated mechanisms), upregulate type II collagen and aggrecan synthesis through MAPK and Wnt/β-catenin pathway activation, suppress matrix-degrading enzymes (MMPs) through TIMP upregulation, and reduce inflammatory mediators in joint tissues through NF-κB inhibition—collectively promoting cartilage matrix deposition and repair while reducing destructive inflammation.
What to expect
Days 1-14 (during treatment course)
What you might notice
- Minimal cardiovascular changes initially — vascular gene expression reprogramming is building
- Possible mild headache or blood pressure fluctuation as endothelial function begins normalizing
- Mild fatigue as vascular remodeling processes activate
- Peptide-DNA binding at vascular gene promoters is activating extracellular matrix restoration programs
What's normal
- Vascular remodeling is a slow process — arterial stiffness doesn't resolve overnight
- Cholesterol changes require hepatic and vascular gene expression changes that take weeks
- eNOS upregulation and nitric oxide restoration develop gradually
- Anti-inflammatory effects in vascular tissue are cumulative
What's next
- Continue daily administration for the full 10-20 day course
- Lipid panel improvements typically become measurable 4-8 weeks after starting
- Full vascular remodeling continues beyond the active treatment course
Week 2-8 (during and after treatment)
What you might notice
- Gradual improvements in blood pressure readings
- Better exercise tolerance and reduced exertional symptoms
- Improved peripheral circulation (warmer extremities, better skin tone)
- Measurable improvements in lipid panel on follow-up blood work
What's normal
- Arterial elasticity is improving through elastin/collagen normalization
- Endothelial nitric oxide production is substantially enhanced
- Vascular inflammatory markers are reducing
- Cholesterol reduction (up to 30%) reflects hepatic gene expression changes
What's next
- Follow-up lipid panel recommended 6-8 weeks after treatment initiation
- Benefits continue developing as vascular remodeling progresses
- Plan next course in 3-6 months to maintain and extend cardiovascular improvements
Month 2-6 (inter-course period)
What you might notice
- Sustained improvements in cardiovascular function and lipid profiles
- Maintained blood pressure normalization and arterial compliance
- Ongoing cardiovascular geroprotection from persistent vascular gene changes
- Benefits may gradually diminish, indicating readiness for next course
What's normal
- Epigenetic modifications to vascular genes persist beyond the treatment course
- Cyclical treatment every 3-6 months maintains and extends cardiovascular benefits
- Each subsequent course reinforces vascular tissue normalization
- Long-term follow-up demonstrates sustained cardiovascular protection over years
Signs it's working
Treatment Response
- Improvement in the primary symptoms or condition being treated
- Positive changes in relevant lab values or clinical markers
- Consistent, stable response to Ventfort over time
- Reduction in symptom frequency or severity
General Well-being
- Improved energy levels and daily functioning
- Better quality of life related to the treated condition
- Manageable or absent side effects indicating good tolerance
- Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- Insufficient time at target dose—most compounds need several weeks to show full benefits
- Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- Individual variation in response—genetics, metabolism, and other factors affect outcomes
- Underlying conditions or medications interfering with absorption or effectiveness
- Improper storage leading to degraded product—always verify proper storage conditions
Key research
Questions
Frequently asked
What is Ventfort and how is it different from synthetic peptide bioregulators?
Ventfort is a tissue-derived peptide complex extracted from bovine aorta, containing a mixture of ultrashort peptides up to 5 kDa including the KED (Lys-Glu-Asp) tripeptide. Unlike purely synthetic single-peptide bioregulators (like Vilon/KE or Epithalon/AEDG), Ventfort provides a complex of multiple vascular-specific peptides that work together. This mirrors the approach of Thymalin (thymic extract) and Cortexin (brain extract) — tissue extracts that contain the full spectrum of organ-specific peptides rather than a single purified sequence.
How did the 49-patient trial demonstrate 30% cholesterol reduction?
In a controlled clinical study of 49 patients with cardiovascular conditions, Ventfort treatment resulted in approximately 30% reduction in total cholesterol levels over the treatment period. This effect is attributed to modulation of hepatic and vascular lipid metabolism gene expression through epigenetic mechanisms — the constituent peptides bind to DNA at promoters of genes controlling cholesterol synthesis, LDL receptor expression, and lipid transport, effectively reprogramming lipid metabolism at the gene level.
Can Ventfort replace statin medications?
Ventfort should not be considered a replacement for prescribed statin medications, particularly in patients with established cardiovascular disease or high cardiovascular risk. While the 30% cholesterol reduction observed clinically is comparable to moderate-intensity statin therapy, Ventfort lacks the extensive clinical trial evidence base that supports statins. It may be considered as adjunctive support alongside conventional therapy or for individuals who cannot tolerate statins, but always under medical supervision.
How does Ventfort restore arterial elasticity?
Arterial stiffness results from age-related changes in the vascular extracellular matrix — loss of elastin, increased collagen crosslinking, and dysregulated MMP activity. Ventfort's constituent peptides bind to gene promoters controlling elastin synthesis, collagen production, and MMP expression, rebalancing the extracellular matrix composition toward a more youthful elastic state. This is fundamentally different from vasodilators that temporarily relax vessel walls — Ventfort aims to reverse the structural changes in arterial walls.
What is the KED peptide found in Ventfort?
KED (Lys-Glu-Asp) is a tripeptide identified as one of the key active components in Ventfort's complex peptide mixture. It interacts with DNA minor groove at vascular gene promoter sequences, similar to how Vilon's KE dipeptide binds to GCGG sequences in immune genes. KED has been studied independently and shown to modulate vascular gene expression, but within Ventfort it works in concert with other aorta-derived peptides for comprehensive vascular bioregulation.
How does Ventfort fit into a comprehensive anti-aging protocol?
In Khavinson's bioregulator system, Ventfort addresses cardiovascular aging specifically. A comprehensive anti-aging protocol might include: Ventfort (vascular), Epithalon (pineal/melatonin), Vilon (immune), Cerluten (brain), and organ-specific peptides like Testagen (testicular) or Chonluten (lung) depending on individual needs. These are used in cyclical courses of 10-20 days, repeated every 3-6 months, with each peptide targeting its specific organ system through tissue-specific DNA binding.
Further reading
History & related research
History · since 1989
The Vascular Wall Restorer - Engineered for Cardiovascular Resilience
Ventfort is a synthetic tripeptide bioregulator comprising the amino acid sequence lysine-glutamic acid-aspartic acid (Lys-Glu-Asp, or KED). Developed by Professor Vladimir Khavinson at the St.
Read the full history of VentfortReady for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Ventfort, on one page.